Esonarimod-impurities | Pharmaffiliates

Esonarimod

Esonarimod, a propionic acid derivative, for the treatment of rheumatoid arthritis.Taisho Pharmaceutical in Japan was developing esonarimod. Reference standards of Esonarimod API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Esonarimod-API
    [catalogue_number] => PA 05 1700000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 280.34
    [form] => C14H16O4S
    [cas] => 101973-77-7
    [pslug] => 101973-77-7-esonarimod-api-pa051700000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 05 1700000

Esonarimod-API


  • Catalogue No.:PA 05 1700000

  • CAS :

    101973-77-7

  • Molecular Formula : C14H16O4S

  • Molecular Weight : 280.34